Finland· FI-REL-REL2168
Recipect
A opium-derivate und expektoranzien product containing codeine phosphate hemihydrate + guaifenesin, registered in Finland by Orion Corporation. The same ATC class is registered in 5 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Opium-derivate und expektoranzien is registered in 5 of 19 countries.
Countries holding a registration under ATC R05FA02 (opium-derivate und expektoranzien), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Opium-derivate und expektoranzien · ATC R05FA02
5 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Norwayprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Codeine phosphate hemihydrate + Guaifenesin
- Manufacturer
- Orion Corporation
- Country
- Finland (FI)
- ATC code
- R05FA02
- ATC class
- Opium-Derivate und Expektoranzien
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Opium-derivate und expektoranzien in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCodeine-GuaifenesinNuCare Pharmaceuticals,Inc.
- SwitzerlandResyl plus, TropfenSpirig HealthCare AG
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Austria · Resyl Mit Codein
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/faa285cf-cd67-4539-8dad-d12de321e1ec GET /v1/drugs/faa285cf-cd67-4539-8dad-d12de321e1ec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "9",
"form": "oraaliliuos",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": null,
"atc_label": "opiumjohdokset ja ekspektorantit, lukuun ottamatta mukolyyttejä",
"ma_number": "9537",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL2168",
"authorised_at": "1987-09-30"
}See everything about opium-derivate und expektoranzien.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.